HSAC2 amends backstop and forward purchase agreements with RTW Funds for Orchestra deal

Orchestra BioMed Holdings, Inc.

Per-share purchase price under both agreements capped at the shareholder redemption price (not exceeding $10.00).
RTW Funds agree not to vote shares purchased under these agreements in favor of the business combination.
RTW Funds waive redemption rights for those shares in connection with the vote to approve the combination.
Amendments executed on October 21, 2022, modifying the July 4, 2022 agreements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.